FDA Adverse Event
Malfunction
Summary report: N
FLEXTEND II
MDR report key: 2041815
·
Received April 6, 2011
Report
- Report Number
- 2124215-2011-01156
- Event Type
- Malfunction
- Date Received
- April 6, 2011
- Date of Event
- December 19, 2010
- Report Date
- January 13, 2011
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVN
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
NO FURTHER PATIENT EFFECTS WERE REPORTED. AN ATTEMPT WAS MADE TO RETRIEVE ADDITIONAL INFORMATION FROM THE FIELD CONCERNING THE FINAL OUTCOME OF THIS EVENT, HOWEVER, NO FURTHER INFORMATION HAS BEEN RECEIVED. AS NO FURTHER INFORMATION CONCERNING THIS REPORT IS EXPECTED, OUR INVESTIGATION IS COMPLETE. THIS INVESTIGATION WILL BE UPDATED SHOULD FURTHER INFORMATION BE PROVIDED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THE PATIENT IMPLANTED WITH THIS RIGHT ATRIAL (RA) LEAD HAD INCREASING HEART FAILURE SYMPTOMS. DURING A FOLLOW-UP, IT WAS NOTED THE RA LEAD HAD DISLODGED. THE PATIENT WAS HOSPITALIZED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | FLEXTEND II | IMPLANTABLE LEAD | NVN | CPI - DEL CARIBE | 4096 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| O |